MedTrace Logo

The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy

NCT03040856 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-04-14

No results posted yet for this study

Summary

Omega-3 fatty acids are "good fats," and are among the most important nutrients lacking in Western diets today. The average person in developing countries consumes less than 100 mg of DHA daily. With increasing awareness of the importance of DHA, many people realize that they need to make a change in their diet by adding DHA-rich foods or supplements.

The aim of this study is to learn the effect of different supplementations from the omega 3 group on the maternal and fetal fatty acid profile during pregnancy and to study their epigenetic influence.

Conditions

  • Omega 3 Supplements During Pregnancy

Interventions

DIETARY_SUPPLEMENT

Alpha Linolenic Acid

Alpha Linolenic Acid enriched diet

DIETARY_SUPPLEMENT

Omega 3 enriched diet ( DHA+EPA)

Omega 3 (DHA+EPA) supplementation enriched diet

OTHER

Placebo

Placebo capsules containing olive oil

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Israel Hendler, M.D · Department of Obstetrics and Gynecology ,Sheba Medical Center, Ramat Gan, Israel

  • Alicia Leikin-Frenkel, M.D, Ph.d · Bert Strassburger Lipid Center, Sheba Medical Center, Ramat Gan, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040856 on ClinicalTrials.gov